Crizanlizumab vs Osimertinib

## Crizanlizumab vs Osimertinib: Overview

This comparison examines the pharmacological differences between **Crizanlizumab** and **Osimertinib**.

## Mechanism of Action

**Osimertinib**: Third-generation irreversible EGFR TKI targeting T790M resistance mutation and activating mutations.

## Pharmacokinetics

**Half-life**: Crizanlizumab — N/A; Osimertinib — 48 hours.

## Chemical Properties

**Molecular Formula**: Crizanlizumab — N/A; Osimertinib — C28H33N7O2.

**Molecular Weight**: Crizanlizumab — N/A; Osimertinib — 499.6050 g/mol.

**Type**: Crizanlizumab — Antibody; Osimertinib — Small molecule.